Context: Based on ethno-botanical information collected from diabetic patients in Cuba and first reported as inhibiting PTP1B and DPPIV enzyme activities, Allophylus cominia (A. cominia) was identified as possible source of new drugs that could be used for the treatment of Type 2 diabetes mellitus (T2-DM).
Introduction
Type 2 diabetes (T2-DM) is considered to be one of the most severe of all chronic diseases, and is one of the most widely-known metabolic illnesses . It has been estimated that there are 180 million diabetic patients worldwide and this number is expected to double by 2030 (WHO, 2005) . T2-DM is commonly associated with obesity (diabesity) and insulin resistance (hyper-insulinemia) is the salient feature of T2-DM and obesity. Several drugs are used for the treatment of T2-DM; however, these agents have unexpected treatment-limiting side effects. Therefore, there is a need for new anti-diabetic substances (De Souza et al., 2001; Laville and Andreelli, 2000) that have fewer side effects on patients with diabetes and do not induce obesity. Several studies carried out using plant extracts have shown significant effects on glucose uptake (Alonso-Castro et al., 2010; Alonso-Castro et al., 2011; Hassanein et al., 2011; Nomura et al., 2008) and that these plant extracts have the potential to be used in the treatment of diabetes.
In this study, HepG2 cells were used as a model system for the study of the glucose uptake (Hu and Wang, 2011; Wang et al., 2011) . In addition, the L6 cell line was also used as it is a common and useful model for testing glucose uptake (Wang et al., 1999; Jia et al., 2010) .
Fully differentiated adipocytes are insulin-responsive and take up glucose more effectively than pre-adipocytes, with a high number of glucose transporter-4 (GLUT4) enhanced by the insulin from the intracellular compartment to the cytoplasmic membrane, resulting in an increase in the glucose uptake with lower insulin concentrations.
2-NBDG, a novel fluorescence glucose analogue probe that was initially developed to measure glucose uptake rates in cells, has also proven to be of great utility in measuring glucose uptake rates in a wide range of non-mammalian and mammalian cells in recent years. 2-NBDG has shown to be transported intracellularly by the same glucose transporters (GLUT4) as glucose.
2 deoxy-D-glucose, which is known to compete with 2-NBDG in mammalian cells, has also been used (Hassanein et al., 2011) . However, 2-NBDG is known to be phosphorylated by the kinases (hexokinases) as glucose. Therefore, 2-NBDG can be trapped within the cells for an extended period of time, and can be used to monitor glucose uptake; however, phosphorylation of 2-NBDG leads to rapid degradation into non-fluorescent products. Many studies have shown that TNF-α inhibits adipogenesis and 3T3-L1 differentiation by down regulation of microRNAs (Cawthorn et al., 2008) . TNF-α has also been reported in some studies to contribute to apoptosis in many cell lines (Krown et al., 1996) . In type 2 diabetic patients, troglitazone acts as an insulin-sensitising agent. Troglitazone prevents the inhibitory effects of inflammatory cytokines such as TNF-α on insulin-induced adipocyte differentiation in 3T3-L1 cells (Bouaboula et al., 2005) . Troglitazone has been used in studies for enhancing adipocyte differentiation in vitro (Khil et al., 1999) . It has been suggested that the decrease in lipid accumulation in 3T3-L1 cells may be associated with the expression of GLUT4 transporters translocation in the cell membrane (Moon et al., 1990) .
Allophylus cominia (L.) Sw (Sapindaceae), also known as Rhus cominia (L.) or Schmidelia cominia Sw, commonly known as palo de caja, caja or caja común, is one of the best-known medicinal plants in Cuba. It was initially used as a remedy for gastrointestinal disorders, but was subsequently employed as a remedy for diabetes (Roig, 1988 and Marrero, 2007) . Its use has also been reported in cases of tuberculosis and catarrhal diseases in general. In addition, medicinal properties against toothache and as a blood purifier in venereal diseases have also been attributed to this plant (Roig, 1988; Maria De Los Angeles and Gerald, 2003; García Mesa, 2014 and Marrero, 2007) . Further experimental in vivo studies concluded that aqueous extracts from A. cominia leaves have antidiabetic properties and may be effective in the treatment of Type 2 diabetes (Sánchez and Marrero, 2014) . Some plant uses have a common origin in the ethno-botanical practices of Caribbean people of African cultural heritage, the socalled Afro-Caribbean pharmacopoeia: examples include the use of the aerial parts of Lippia alba and Cymbopogon citratus, as well as the use of the roots and ligneous parts of Allophylus cominia, Caesalpinia bahamensis, Erythroxylum havanense, and Chiococca alba. The Afro-Caribbean pharmacopoeia is that body of knowledge and practices of medicinal plants which has its origins in the cultures of African slaves brought to the Caribbean (Laguerre, 1987) .
Even though the plant we studied is known to be used as an anti-diabetic in ethno-botany, pharmacological and phytochemical studies are still needed to explain the mechanism involved in the biological activity and its relevance, as well as to identify the compounds responsible for such effects regarding therapeutic targets involved in metabolic disorder diseases, Type 2 diabetes and obesity. The aim of this study was to investigate the effect of the extracts from A. cominia (in vitro) on glucose uptake using three different cell lines, as well as on 3T3-L1 differentiation, the formation of lipid droplets in 3T3-L1 cells and on the number of GLUT4 transporters.
Materials and methods

Cell culture and adipocyte differentiation
HepG2 (Hepatocellular carcinoma, human) and L6 cells (muscle cells) (donated by SIDR, University of Strathclyde) were maintained in DMEM (Dulbecco's Modified Eagle's Medium from Gibco, Invitrogen, UK), supplemented with 10% FBS (Foetal Bovine serum), 100 U/mL of penicillin, and 100 μg/mL of streptomycin (Hu et al., 2011) and incubated at 37ºC in a humidified atmosphere containing 5% CO2 in air until 70-90% confluent. 3T3-L1 fibroblasts (ZenBio, Inc., SP-L1-F) were seeded as HepG2, reaching no more than 70% confluence; these cells were plated in DMEM 10% NBS (newborn serum), two days post-confluence. 3T3-L1 cells were treated with a differentiation cocktail DMEM (MDI differentiation media) (Tang and Lane, 2012) supplemented with 10% FBS, 1µg/ml of insulin, 0.25 µM dexamethasone and 0.5 mM IBMX (3-Isobutyl-1-methylxanthine). Two days following differentiation, the media was replaced with DMEM (10% FBS) containing 1 µg/ml insulin and 1 µM of troglitazone.
On day 5, the media was replaced by DMEM containing 10% FBS and cells were fed with the same media until the end of the experiment.
Extracts from A. cominia
As explained in a previous report of the same study (Semaan et al., 2017) , the phytochemical separation and identification of the compounds from the Cuban plant Allophylus cominia revealed the existence of a mixture of flavonoids (quercetrin and mearnsitrin, in addition to other minor flavonoids and fat) and a mixture of pheophytins (a and b). However, of the extracts fractionated from A.comina, all were investigated for anti-enzyme activities (DPPIV, PTP1B, α-glucosidase and α-amylase) (Semaan et al., 2017) . The effect of fractions that showed more than 70% inhibition of PTP1B enzyme activity on glucose uptake was subsequently investigated using various cell lines. However, only the mixture of flavonoids and pheophytin A were followed for further assays.
Cytotoxicity tests
To evaluate cell viability of HepG2, L6, 3T3-L1 fibroblasts and adipocytes, cells were seeded at 1x10 4 cells/ml in 96-well culture plates and incubated for 24 h at 37ºC in a humidified atmosphere containing 5% CO2. A. cominia extracts were added at 100-1 μg/ml and incubated for a further 24 h. Cell viability was tested using Alamar Blue ® (Goegan et al., 1995) , where 10% of the dye was added to the cells and incubated for 6 h at 37ºC in 5% CO2; the fluorescence intensity was measured using a WallacVictor 2 1420 Multilabel counter at ex560-/em590nm. MTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay was also used as cell viability test where 20% of MTT (purchased from Sigma Aldrich, UK, working solution of 5 mg/ml in PBS) was added to the cells and incubated for 4 h at 37ºC in a humidified atmosphere containing 5% CO2; cells were then solubilised in 100% DMSO for 5 min. The absorbance was measured using a Spectramax micro-plate reader at 570nm.
Oil Red O staining and measurement of fats
Eight days post-differentiation, 3T3-L1 adipocytes grown in 12-well plates were washed twice with PBS (phosphatase buffer saline), fixed with 10% of formalin in PBS, and then incubated at 37ºC in a humidified atmosphere containing 5% CO2 for 1.5 h. After removing the fixing solution, the cells were washed three times with distilled water. 1ml of oil Red-O dye was added to each well and left at room temperature for 1 h. The dye was removed and the cells were washed three times with distilled water. To measure the fat content, 100% isopropanol was added and cells were left at room temperature for 10 min to allow the cells to release the dye. The optical density was measured at 540 nm using a Spectramax micro-plate reader.
2.5.Glucose uptake assay
HepG2 and L6 cells were seeded at 1x10 4 cells/ml in a black clear bottom 96-well plate (purchased from Fisher Scientific, UK) for a direct 2-NBDG glucose uptake test. Before assaying, cells were pre-incubated at 37ºC with extracts of A. cominia (100µg/ml) for 24 h; subsequently the media was replaced with Krebs-Ringer phosphate buffer (KRB) containing the plant extracts and incubated for 4 h. Further to this, 100 nM insulin was added in KRB buffer and cells were incubated for 45 min, when 100 µM of 2-N-7-(nitrobenz-2-oxa-1,3diazol-4-yl)amino-2-deoxy-D-glucose (2-NBDG) was added and the plate was incubated at 37ºC for 1 h. The reaction was terminated by washing the cells twice with ice cold PBS (Leira et al., 2002; Zou et al, 2005) . The fluorescence intensity of 2-NBDG was measured on a Wallac Victor2 1420 Multi-label Counter using the excitation/emission wavelengths 485/535nm.
Protein assay method
Protein assay (Quick Start Bradford protein assay kit purchased from BioRad Laboratories, USA) was used for a simple and accurate procedure to determine the concentration of protein in solution. 3T3-L1 cells were pre-treated and differentiated in 25 cm 2 flasks and cells were harvested in lysis buffer. BSA and Gamma-Globulin were used as standards for studying the linear range of the assay, which was 125-1000 µg/ml with BSA and 125-1500 µg/ml with Gamma-Globulin. Standards or unknown samples from the pre-treated 3T3-L1 cells with troglitazone, TNF-α, flav and pheo were added to a 96-well clear plate (5 µl/well). Fibroblast cells were used as control. Blank was made using water and dye reagent. 1X dye reagent was then added to each well (250 µl/well). The dye reagent was removed from the 4ºC storage and warmed up at room temperature before each use. Samples and standards were incubated with the dye reagent at room temperature for 10 min (not more than an hour) and then the absorbance was read with a Spectramax micro-plate reader using 595 nm.
Western blot
3T3-L1 cells were seeded and differentiated, in a 25 cm 2 flask, addition of TNF-α (10 ng/ml), flavonoids and pheophytins from A. cominia at 100 µg/ml was done from the beginning of the differentiation process. Three days post-differentiation, cells were washed twice with PBS.
Cells were harvested and transferred into Eppendorf tubes in PBS. The PBS was removed by centrifugation at 600 x g for 5 minutes at 4ºC using microfuge Sigma 1-15K. Supernatant was discarded and cell pellet was washed twice with 1 ml of PBS. Cell pellets were re-suspended in 1ml 1X lysis buffer (10X lysis buffer stock were diluted 10-fold with 9 ml of 18 megohm water). Cells were incubated on ice for 20 minutes, and then centrifuged at 18000 x g for 15 minutes at 4ºC. The supernatants containing cell proteins were transferred into new Eppendorf tubes and analysed immediately. SDS PAGE was carried out by preparing 12% of resolving gel (RB, about 4.65 ml/gel) and 4% of stacking gel (SB, about 1 ml/gel), where RB was prepared by 5 ml (2X) RB, 4 ml acrylamide, 1 ml distilled water, 200 µl of APS and then 8 µl TEMED. SB (4%) was prepared by 4 ml (2X) SB, 1.2 ml acrylamide, 2.8 ml distilled water, 200 µl of APS, and finally the addition of 10 µl TEMED. Then the gel was added on top of the set resolving gel, and lanes were made using a comb. The samples were then loaded at 30 µl per lane and a marker with low molecular weight was used as a control (15 µl), using a Hamilton syringe. The gel was run for half an hour at 80 mV, which was then increased to 150 mV for one hour. The transfer of the proteins was done by disassembling the gel plates; the gel was placed in transfer cassettes, and then the transfer was run in transfer buffer (25 mM Tris base, 0.2 M glycine, 20% methanol and pH 8.9) at 120 mA at constant AMPS and left overnight. The gel was treated with 5% SCHIM (proteins) for an hour at room temperature prior to being incubated with Abcam antibody (1:1000, Glucose Transporter GLUT4). The cyclophilin B antibodies were purchased from Abcam PLC (Cambridge, U.K.). The polyclonal GLUT4 antibody was raised in rabbit with the immunogen located in the C-terminus of GLUT4. The polyclonal cyclophilin B antibody was raised against a C-terminal peptide of human cyclophilin B), and then a secondary antibody IRdye (1:12500) was added. The plate was washed three times with PBST (phosphatase buffer saline Tween 0.02% volume) for 10 minutes after the addition of the first and the second antibodies. Finally, the plate was scanned under a LI-COR Odyssey infrared scanner and the results were analysed by Licor Studio Image Lite software.
Statistical analyses
Data were expressed as mean ± SEM. Graphs were generated using GraphPad Prism version 4 software. The data were analysed statistically by one way ANOVA analysis of variance and Dunnett's post-hoc test. The level of statistical significance was set at P < 0.05.
Results
Effect of extracts from A. cominia on cell viability
Extracts of A. cominia (1 -100 µg/ml) were first tested to determine their effect on cell viability; no cytotoxic effects were shown with either Alamar Blue ® or MTT based cytotoxicity assays (data not shown).
The effect of insulin and A. cominia extracts on 2-NBDG glucose uptake using HepG2 and L6 cells
The uptake of 2-NBDG by HepG2 cells was enhanced by 100 μg/ml of the fraction containing flavonoids in the presence or absence of 100 nM insulin (Fig 1.A) . However, the extract containing the pheophytins had no effect on glucose uptake in this cell line. In the absence of insulin, 2-NBDG uptake by HepG2 cells was increased nine-fold. In the presence of insulin uptake, of 2-NBDG was fivefold higher than that without 100 nM insulin. However, in the presence of both 100 nM insulin and 100 μg/ml flavonoids, 2-NBDG uptake was increased by eleven-fold as shown in Fig 1. A.
2-NBDG glucose uptake was carried out in L6 cells treated for 24 h with 100 µg/ml flavonoids or pheophytins in the presence of 100 nM of insulin (Fig 1.B) . By comparison with the glucose uptake by non-treated cells (no insulin), uptake was significantly (p<0.05) increased in the presence of flavonoids extracts and greatly increased in the presence of pheophytins extract. 
Effect of extracts from A. cominia on 2-NBDG glucose uptake by HepG2 and L6 cells
As shown below in Fig 2. A, insulin produced a concentration-dependent increase in 2-NBDG glucose uptake in HepG2 cells with EC50 93 ± 21 nM. In the presence of 100 μg/ml of AC crude extracts, the potency of insulin in increasing 2-NBDG uptake by HepG2 cells increased, with a 6.7-fold reduction in EC50 to 13 ± 2 nM (Fig 2B. ). As shown in Fig 3. A, there was a small increase in 2-NBDG glucose uptake by L6 cells with an increasing concentrations of insulin in the absence of AC (EC50 28.6 ± 0.7 nM). L6 cells were treated for 24 hours with 10 and 100 µg/ml of flavonoids or pheophytin A. As shown in Figs 3.B and 3.C, insulin produced a concentration-dependent increase of the glucose uptake.
Effect
In the presence of 100 µg/ml flavonoids and pheophytins, the uptake increased and EC50 decreased to 0.08 ± 0.02 nM and 5 ± 0.9 nM, respectively. 
Effect of extracts from A. cominia on 2-NBDG glucose uptake by 3T3-L1 fibroblasts and adipocytes
Insulin produced a concentration-dependent increase in glucose uptake in 3T3-L1 fibroblasts and fully-differentiated adipocytes. A marked enhancement of insulin-stimulated glucose uptake by 3T3-L1 fibroblasts was seen in the absence of A. cominia (Fig 4.A) . A significant increase in 2-NBDG glucose uptake was shown in the presence of A. cominia methanolic crude extract by comparison with the control (in the absence of insulin) was added to the 100 µg/ml of A. cominia methanolic extract. In the presence of 100 µg/ml of the crude methanolic extract from A. cominia (AC), insulin produced a concentration-dependent increase in glucose uptake.
No significant difference was shown in the presence of AC extract (Fig 4.B) . However, AC extract did not enhance insulin activity in comparison to the cells untreated by AC. An increase in 2-NBDG uptake by 3T3-L1 fibroblasts was shown (Fig 4.A) in the presence and absence of the methanolic crude extract from A. cominia with increases in insulin concentrations;
however, the effect of the extract was small (Fig 4.A) . The EC50 of insulin without AC was >1000 nM and in the presence of the extract, the EC50 was 38 ± 4 nM. Thus, AC enhances insulin activity. Insulin (100 nM) produced an increase of glucose uptake in fully differentiated 3T3-L1 adipocytes by comparison to the basal level where no insulin was added (Fig 4.C) . The crude extract of A. cominia did not show any enhancement of 2-NBDG uptake by 3T3-L1 adipocytes in the presence or absence of 100 nM insulin (Fig 4.D) . 
Effect of flavonoids on 2-NBDG uptake by 3T3-L1 fibroblasts
Effect of A. cominia extracts on the differentiation of 3T3-L1 cells
In comparison to control cells, there was an increase in the optical density the presence of troglitazone, and significant decrease was shown with TNF-α. The effect of both flavonoids and pheophytins on lipid accumulation decreased by one-fold as compared to the control (P<0.05) ( Fig 5.A and 5 .C). When the extracts were added after differentiation had been established (day 3), there was no decrease in lipid accumulation ( Fig 6) . 
Control Troglitazone
Effect of extracts of A. cominia on 3T3-L1 lipid accumulation
As shown in Fig 7, the addition of flavonoids had no effect on lipid accumulation after 24 h; therefore, a decrease in the lipid droplets was clear after 48 h and 72 h. Pheophytins significantly decreased lipid droplets in 3T3-L1 adipocytes 24 h after addition of the extract, and this decrease was significantly greater after 48 h and 72 h. 
Effect of withdrawal of extracts from A. cominia on the accumulation of lipid in 3T3-L1 cells
A significant decrease of the lipid droplets inside the cells was clear, starting from 24 h of the addition of 100 µg/ml of the flavonoids and pheophytins extracts from A. cominia (Fig 8) . The change of the OD decreased significantly over days, even after 5 days by comparison to the control untreated cells. After 6 days of withdrawal of the extracts, the medium was replaced with normal growth medium supplemented with 10% FBS. By comparison to the control, no fat re-accumulation was observed in the pre-treated cells with extracts of A. cominia. The cells pre-treated with the flavonoids containing extract showed fewer fat droplets inside the 3T3-L1 adipocytes after 5 days of the treatment (Fig 9.B ) compared with the control cells (Fig 9.A) .
Effect of addition and withdrawal of flavonoids and pheophytin A on 3T3-L1 lipid droplets accumulated in the cells over days The blue circles surround differentiated cells with fewer fat droplets in them.
Effect of the extracts from A. cominia on protein concentrations in 3T3-L1 adipocytes
As shown in Fig 10.A, BSA (standard) produced a concentration-dependent increase in the absorbance at 595 nm. The unknown sample concentrations were calculated using the equation presented in Fig 10. A and the results are presented in Table 1 . Lysis buffer was used as blank and did not show high protein concentration. No significant difference between adipocytes, fibroblasts and the pre-treated cells with TNF-α, flavonoids and pheophytin A was shown.
Furthermore, compared to the protein concentration in the fibroblasts cell lysate that was used as control, all the other metabolites from the pre-treated cells with troglitazone, TNF-α, flavonoids and pheophytin A were similar in the total protein concentrations in these cell lysates (Fig 10.B) . Protein concentration was about 1300 -1600 µg/ml as calculated from BSA standard curve. All the results confirmed that these cell lysates contain similar protein concentrations and were able to be used for further Western blot for the identification and quantification of the GLUT4 transporters in these pre-treated 3T3-L1 cells. 
Effect of the extracts from A. cominia on insulin-mediated GLUT4 transporters
GLUT4 transporters from differentiated 3T3-L1 cells appeared around 46 kDa (Fig 11.A) ,
represented by prominent bands, whereas, cells treated with TNF-α showed lighter bands. The effect of TNF-α, flav and pheo was confirmed in Fig 11. B, while a significant decrease of GLUT4 transporters only appeared in the TNF-α pre-treated 3T3-L1 cell line. Flavonoids and pheophytin A did not affect the GLUT4 transporters in the 3T3-L1 intracellular-membrane. 
Effect of extracts from
Discussion and conclusion
Both flavonoids and pheophytin A stimulate glucose uptake. However, the flavonoids and pheophytins were both in a mixture of compounds and the ratio of each compound in each sample was not identified. Therefore, further work should be carried out to confirm these ratios and to compare them with a specific biomarker as a reference. It is possible that the inhibition of PTP1B contributed to the enhancement of the glucose uptake as well as to the enhancement of insulin sensitivity in differentiated 3T3-L1, L6 and HepG2 cells. The mixture of flavonoids produced the greatest effect on glucose uptake, with 100% inhibition of PTP1B enzyme (Semaan et al., 2017) . PTP1B enzyme inhibition enhanced insulin activity of A. cominia by this mechanism. This was supported by reports about the effect of flavonoids on peripheral insulin sensitivity (Brahmachari, 2011; Strobel et al., 2005; Nomura et al., 2008) . The hypoglycaemic activity of many plants has been linked to the presence of steroidal glycosides (McAnuff et al., 2005; Kato et al., 1995; and Dhanabal et al., 2005) .
Insulin produced a concentration-dependent stimulation of 2-NBDG uptake (compared to the untreated control cells) by HepG2, 3T3-L1 fibroblasts, adipocytes and L6 cells, which confirms that these cell lines were responsive to insulin. An important functional aspect of these cells, particularly differentiated 3T3-L1 adipocytes, is insulin sensitivity. Insulin EC50 of 93 ± 21 nM in HepG2 cells decreased to 13 ± 2 nM in the presence of the methanolic crude extract of AC.
In 3T3-L1 fibroblasts, insulin had an EC50 of >1000 nM which decreased to 38 ± 4 nM in the presence of AC extract. However, in adipocytes, insulin produced a significant concentrationdependent increase and an EC50 of 30 ± 8 nM was a further confirmation of the insulin responsiveness of the adipocytes to the insulin. The results are consistent with the general observation that newly developed adipocytes show increased insulin responsiveness and take up more glucose than fibroblasts (Xu et al., 2006) . In L6 cells, insulin also produced a concentration-dependent increase with an EC50 of 28.6 ± 0.7 nM; EC50 decreased to 0.08 ± 0.02 nM and 5 ± 0.9 nM in the presence of 100 μg/ml of flav and pheo, respectively. This serves to confirm the importance of AC extracts in lowering the insulin concentration needed in diabetic models by enhancing insulin activity. Many researchers have shown that the stimulation of glucose uptake by HepG2, L6 and 3T3-L1 fibroblasts is a well-recognised mechanism of action of anti-diabetic drugs and plants which have insulin-like activities Wang et al., 1999; Xu et al., 2006; Hu and Wang, 2011) . However, the activity of A. cominia extracts on 2-NBDG glucose uptake reported in this project did not provide any information on the mechanism pathways involved in producing this activity; thus, further work is required.
Flavonoid and pheophytin extracts from A. cominia decreased lipid accumulation in 3T3-L1 once added from the first day of the initiation of the differentiation process. No effect was shown once added after three days of the differentiation initiation. This confirms that these extracts, as well as TNF-α, are only active at the beginning of differentiation. This can be related to the expression of PPARγ, which plays an important role as an essential regulator in adipocytes differentiation (Saito et al., 2007) . Extracts from A. cominia decreased lipid droplets accumulated in the cells over days. However, no lipid re-accumulation was shown after removal of the extracts over days. This can be related to the lipolytic effect of these extracts.
Lipolysis in adipocytes is known to be triggered by an increase of intracellular cAMP level.
cAMP activates protein kinase A and downstream lipases (Saito et al., 2007) . Cells pre-treated with TNF-α showed a decrease in GLUT4 transporters in comparison to that of the adipocytes, as in the undifferentiated control fibroblasts, confirming that the decrease in GLUT4
transporters is due to TNF-α (Stephens et al., 1997) . Flavonoids seemed to work differently than TNF-α. It has been reported (Moon et al., 1990; Lee et al., 1994; Khil et al., 1999) that the hypo-glycaemic action of compounds may be due to the stimulation of glucose transport and metabolism in insulin target organs, such as 3T3-L1 adipocytes. The translocation of GLUT4 transporters is mediated by the fusion of the plasma membrane and vesicles containing GLUT4 proteins, in which the intracellular calcium causes conformational changes in the membrane compartment to facilitate the translocation process (Muller et al., 2014) . The mechanism of action of flavonoids may be involved in the blockage of GLUT4 receptors rather than decreasing their translocation, thus preventing the cells from the uptake of nutrients and accumulation of fat droplets, which further implies that glucose uptake by 3T3-L1 adipocytes did not increase in the presence of flavonoids in the absence of insulin. Previous results in adipocytes showed that flavonoids inhibited the uptake of methylglucose, a substrate that enters the cells through GLUT4 transporters in 3T3-L1 adipocytes (Strobel et al., 2005) . Flavonoids and their related synthetic compounds such as flavones and isoflavones, are tyrosine kinase inhibitors that cause the inhibition of glucose transport (Vera et al., 2001) . As shown in the Western blot, there was an increase in GLUT4 transporters in pheophytin pre-treated cells but not as much as in the control differentiated cells, which shows that the mechanism of action of pheophytin in the differentiation process was different to that of the TNF-α; that is, it blocks the GLUT4 transporters. Lysis buffer was used as blank only in the absence of any cells to ensure that the bands of GLUT4 transporters did not exist. Cells differentiated and treated with staurosporine for 24 hours did not show any GLUT4 transporters, confirming that none of the flavonoid or pheophytin extracts had apoptotic effects. Reduced glucose transporter expression is therefore likely to be a manifestation of impaired differentiation rather than a mechanism to explain reduced differentiation.
It was concluded that flavonoids and pheophytin extracts from A. cominia, with their effect on decreasing lipid droplets in the cells, could be a new candidate to prevent fat formation, thus leading to a decrease in the risk of obesity when associated with diabetes. Obesity is associated with insulin resistance, leading to an increase in the risk of diabetes. This plant was safe and non-toxic in vitro but it is suggested that its side effects be studied in vivo to evaluate it as a new drug candidate to treat diabesity and its clinical manifestations.
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